Betrixaban Synthesis via Coupling Reagents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for an efficient method to synthesize benzamide-based factor Xa inhibitors, such as betrixaban, and their intermediates, which are crucial for treating thrombotic diseases, as existing methods are inefficient and may produce impurities like Compound L and M, affecting purity and yield.
Innovation Solution
A novel synthesis method involving specific reaction conditions and reagents, including amide coupling reagents like EDC.HCl and hydroxybenzotriazole, is used to form betrixaban free base or maleate salt, minimizing the formation of impurities and achieving high purity, particularly on a large scale.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing synthesis methods are used to produce betrixaban, then production can be achieved, but the purity is reduced due to formation of impurities like Compound L and M
Solution Approach 1:
The patent applies parameter changes by optimizing reaction conditions including temperature control (0-25°C), solvent selection (DCM, DMF, NMP), and stoichiometric ratios of reactants to minimize impurity formation and maximize product purity above 99.3%
Solution Approach 2:
The patent uses specific coupling reagents (EDC.HCl, hydroxybenzotriazole) as intermediaries to facilitate the amide bond formation between compounds of Formula II-A and Formula II-B, enabling high-purity synthesis while controlling impurity formation
2Productivity
If existing synthesis methods are used to produce betrixaban, then production can be achieved, but the yield is reduced
Solution Approach 1:
The patent optimizes reaction parameters including temperature (0-25°C), reaction time, and solvent systems to improve reaction efficiency and minimize material loss, achieving high yields through optimized process conditions
Solution Approach 2:
The patent employs slight excess of coupling reagents (EDC.HCl and hydroxybenzotriazole) to ensure complete conversion of limiting reagents, maximizing yield while minimizing unreacted starting materials
3Productivity
If synthesis is performed on large scale, then production efficiency is improved, but maintaining purity and minimizing impurities becomes more difficult
Solution Approach 1:
The patent segments the synthesis process into distinct controlled steps: amide coupling under optimized conditions, followed by separate purification steps, enabling scalable production while maintaining high purity through modular process control
Solution Approach 2:
The patent employs specific solvents and coupling reagents as intermediaries that facilitate scalable synthesis while maintaining product quality, allowing large-scale production with consistent purity through controlled reaction mediators
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces betrixaban with high purity (at least 99.3% free base and 99.7% maleate salt) without significant impurities, ensuring robust and cost-effective large-scale production while maintaining thermal and hydrolytic stability.
Implementation Method 1
contacting a compound of Formula II-A with a compound of Formula II-B under reaction conditions to form the compound of Formula II
Data Source
AI summary
Described herein are novel methods of preparing a compound of Formula II or a pharmaceutically acceptable salt thereof. In some embodiments, the method is for preparing betrixaban or a pharmaceutically acceptable salt thereof. Also described are compositions comprising substantially pure betrixaban free base or salt thereof.